Bioorganic and Medicinal Chemistry Letters p. 243 - 248 (1998)
Update date:2022-08-02
Topics:
Shih, Neng-Yang
Aslanian, Robert
Lupo Jr., Andrew T.
Orlando, Steve
Piwinski, John J.
Green, Michael J.
Ganguly, Ashit K.
West, Robert
Tozzi, Salvatore
Kreutner, William
Hey, John A.
Extensive structural modification of immepyr (+)-2 led to the dsiscovery of trans-4-methyl-3-imidazoyl pyrrolidine (±)-3a as a potent and highly selective H3 agonist. The pyrroline (±)-3a was resolved, and its (+) enantiomer, Sch 50971 [(+)-3a], showed a greater separation of H3 and H1 activities in vivo (H3/H1 ratio >> 330) than (R)-α-methylhistamine (+)-1 (H3/H1 ratio = 17), the standard H3 agonist.
View MoreQingdao Pana-Life Biochem Co.,Ltd.
Contact:86-532-87683902
Address:No.967 Dalao Road, Licang Zone, Qingdao City,Shandong, China 266021
Wuhan Heisenberg Technology Co.,Ltd.
Contact:86-18986005060-18986005060
Address:No.2022 Jiefang Road,JiangAn District
Hangzhou Pharma & Chem Co.,Ltd.
Contact:+86-571-87040515
Address:No,139Qingchun Rd
Shanghai PuYi Chem-Tech Co.,Ltd.
Contact:+86-21-57687505-227
Address:3 Floor, Building 11, No 201 MinYi Road, Songjiang District, Shanghai 201612, China
Sichuan Sangao Biochemical Co., Ltd
Contact:+86-28-84874233
Address:19F, Bldg.2, Shudu Center, Tianfu 2nd St., Hi-tech zone, Chengdu 610041, Sichuan Province, China.
Doi:10.1021/acs.joc.6b02663
(2017)Doi:10.1002/jhet.629
(2011)Doi:10.1002/jhet.5570300137
(1993)Doi:10.1135/cccc19931457
(1993)Doi:10.1016/S0031-9422(00)80770-0
(1985)Doi:10.1021/ja408238n
(2014)